![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Pennington Biomedical Research Center, Baton Rouge, LA 70808
2To whom correspondence should be addressed. E-mail: brayga{at}pbrc.edu.
An increase in the risk of cancer is one of the consequences of obesity. The predominant cancers associated with obesity have a hormonal base and include breast, prostate, endometrium, colon and gallbladder cancers. As the basis for understanding the problem of obesity has advanced, a number of new ideas have emerged about the relationship of obesity to cancer. The conversion of androstenedione secreted by the adrenal gland into estrone by aromatase in adipose tissue stroma provides an important source of estrogen for the postmenopausal woman. This estrogen may play an important role in the development of endometrial and breast cancer. Of interest is that experimental animals lacking aromatase or the estrogen receptor 
are obese. Leptin is one of the many products produced by fat cells and has given rise to the ideas that the fat cell is an endocrine cell and that adipose tissue is an endocrine organ. The increased release of cytokines from this tissue may play a role in the inflammatory state that is associated with obesity. The gut also plays an important role in signaling satiety in response to food intake. Colon cancer is an important human disease, and experimental mice lacking gastrin are obese and have an increased risk of developing colon cancer in response to carcinogenic drugs. Efforts to control obesity through preventive strategies and treatment can be expected to have a benefit in reducing the risk of cancer.
KEY WORDS: • aromatase • fat cells • leptin • gastrin • obesity • cancer
This article has been cited by other articles:
|
|
 |
|
  N. K. Prasad, M. Tandon, S. Badve, P. W. Snyder, and H. Nakshatri Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover Carcinogenesis, January 1, 2008; 29(1): 25 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Banez, R. J. Hamilton, A. W. Partin, R. T. Vollmer, L. Sun, C. Rodriguez, Y. Wang, M. K. Terris, W. J. Aronson, J. C. Presti Jr, et al. Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer JAMA, November 21, 2007; 298(19): 2275 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Freedland and E. A. Platz Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data Epidemiol. Rev., May 3, 2007; (2007) mxm006v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Kumanyika and C. B. Morssink Bridging domains in efforts to reduce disparities in health and health care. Health Educ Behav, August 1, 2006; 33(4): 440 - 458. [Abstract] [PDF]
|
|
|
|
 |
|
 K. P. Keenan, C.-M. Hoe, L. Mixson, C. L. Mccoy, J. B. Coleman, B. A. Mattson, G. A. Ballam, L. A. Gumprecht, and K. A. Soper Diabesity: A Polygenic Model of Dietary-Induced Obesity from Ad Libitum Overfeeding of Sprague-Dawley Rats and Its Modulation by Moderate and Marked Dietary Restriction Toxicol Pathol, October 1, 2005; 33(6): 650 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schroder, J. Marrugat, J. Vila, M. I. Covas, and R. Elosua Adherence to the Traditional Mediterranean Diet Is Inversely Associated with Body Mass Index and Obesity in a Spanish Population J. Nutr., December 1, 2004; 134(12): 3355 - 3361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Catalano, L. Mauro, S. Marsico, C. Giordano, P. Rizza, V. Rago, D. Montanaro, M. Maggiolini, M. L. Panno, and S. Ando Leptin Induces, via ERK1/ERK2 Signal, Functional Activation of Estrogen Receptor {alpha} in MCF-7 Cells J. Biol. Chem., May 7, 2004; 279(19): 19908 - 19915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hirose, K. Hata, T. Kuno, K. Yoshida, K. Sakata, Y. Yamada, T. Tanaka, B. S. Reddy, and H. Mori Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice Carcinogenesis, May 1, 2004; 25(5): 821 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Freedland, W. J. Aronson, C. J. Kane, J. C. Presti Jr, C. L. Amling, D. Elashoff, and M. K. Terris Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group J. Clin. Oncol., February 1, 2004; 22(3): 446 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Catalano, S. Marsico, C. Giordano, L. Mauro, P. Rizza, M. L. Panno, and S. Ando Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line J. Biol. Chem., August 1, 2003; 278(31): 28668 - 28676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Saydah, C. M. Loria, M. S. Eberhardt, and F. L. Brancati Abnormal Glucose Tolerance and the Risk of Cancer Death in the United States Am. J. Epidemiol., June 15, 2003; 157(12): 1092 - 1100. [Abstract] [Full Text] [PDF]
|
|
